These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2681889

  • 1. Environmental conditions favorable for tumor progression in peritoneal cavity induced by peritoneal cells without tumor selectivity.
    Segawa K, Ueno Y, Kataoka T.
    Jpn J Exp Med; 1989 Jun; 59(3):127-33. PubMed ID: 2681889
    [Abstract] [Full Text] [Related]

  • 2. Mitomycin C-augmented production of I-A antigen-positive macrophages in tumor vaccine-primed mice.
    Kataoka T, Yamamoto T, Honjo K, Murayama T.
    Jpn J Cancer Res; 1986 Mar; 77(3):305-11. PubMed ID: 3009373
    [Abstract] [Full Text] [Related]

  • 3. Effect of poly I:C-activated peritoneal cells on the take of transplantable murine tumours.
    Minárovits J, Karczag E, Földes I.
    Acta Microbiol Hung; 1987 Mar; 34(3-4):197-205. PubMed ID: 3129897
    [Abstract] [Full Text] [Related]

  • 4. Two-color flow cytometric analysis of the expression of MAC and MHC class II antigens on macrophages during tumor growth.
    Yurochko AD, Burger CJ, Elgert KD.
    Cytometry; 1990 Mar; 11(6):725-35. PubMed ID: 2200657
    [Abstract] [Full Text] [Related]

  • 5. Effect of recombinant human interferon-alpha A/D on in vivo murine tumor cell growth.
    Uno K, Shimizu S, Inaba K, Kitaura M, Nakahira K, Kato T, Yamaguchi Y, Muramatsu S.
    Cancer Res; 1988 May 01; 48(9):2366-71. PubMed ID: 3356004
    [Abstract] [Full Text] [Related]

  • 6. Immune regulation of the L5178Y murine tumor-dormant state. II. Interferon-gamma requires tumor necrosis factor to restrain tumor cell growth in peritoneal cell cultures from tumor-dormant mice.
    Suzuki Y, Liu CM, Chen LP, Ben-Nathan D, Wheelock EF.
    J Immunol; 1987 Nov 01; 139(9):3146-52. PubMed ID: 3117888
    [Abstract] [Full Text] [Related]

  • 7. Direct and indirect effects of interferon on in vivo murine tumor cell growth.
    Uno K, Shimizu S, Ido M, Naito K, Inaba K, Oku T, Kishida T, Muramatsu S.
    Cancer Res; 1985 Mar 01; 45(3):1320-7. PubMed ID: 2578878
    [Abstract] [Full Text] [Related]

  • 8. Promotion of L1210 tumour growth by macrophages.
    Huget RP, Flad HD, Opitz HG.
    Z Immunitatsforsch Immunobiol; 1978 Sep 01; 154(5):433-41. PubMed ID: 726547
    [Abstract] [Full Text] [Related]

  • 9. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F, Peri G, Villa A, Mantovani A.
    J Immunol; 1984 Feb 01; 132(2):936-44. PubMed ID: 6690624
    [Abstract] [Full Text] [Related]

  • 10. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T, Himeno K, Mitani M, Mori K, Miake S, Nomoto K.
    J Clin Lab Immunol; 1986 Feb 01; 19(2):83-9. PubMed ID: 3083105
    [Abstract] [Full Text] [Related]

  • 11. Development of host-dependent high-grade tumor-specific immunity through a novel mechanism triggered by the Lyt-2+ tumor-specific T cell clone (K7L) that induces temporal growth of L1210 leukemia-K7L-variant.
    Nagase F, Ueda K, Kawashima K, Jamshedur Rahman SM, Isobe K, Yoshida T, Hasegawa Y, Ando K, Iwamoto T, Nagura E.
    J Immunol; 1987 Apr 01; 138(7):2359-65. PubMed ID: 2951438
    [Abstract] [Full Text] [Related]

  • 12. Marked reduction of subcutaneous tumor growth by intraperitoneal administration of recombinant human interleukin 2 with a cell accumulator, proteose-peptone, in mice.
    Tanida S, Uchida H, Taniguchi K, Nomoto K.
    Cancer Res; 1989 Jan 15; 49(2):284-8. PubMed ID: 2783379
    [Abstract] [Full Text] [Related]

  • 13. Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurine.
    Kataoka T, Oh-hashi F.
    Cancer Res; 1985 Jul 15; 45(7):2962-6. PubMed ID: 3873988
    [Abstract] [Full Text] [Related]

  • 14. Suppressive effect of adrenalectomy on growth of L1210 leukemic cells in ascites.
    Kimura K, Sakamoto Y.
    Cell Biochem Funct; 1990 Apr 15; 8(2):91-7. PubMed ID: 2350867
    [Abstract] [Full Text] [Related]

  • 15. Increased macrophage activity in protein A treated tumor regressed animals.
    Prasad AK, Singh KP, Saxena AK, Mathur NK, Ray PK.
    Immunopharmacol Immunotoxicol; 1987 Apr 15; 9(4):541-61. PubMed ID: 3437106
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model.
    Jamieson C, Richter A, Levy JG.
    Exp Hematol; 1993 May 15; 21(5):629-34. PubMed ID: 8513863
    [Abstract] [Full Text] [Related]

  • 17. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL, Wu MS, Chen Z.
    Acta Pharmacol Sin; 2002 Oct 15; 23(10):946-51. PubMed ID: 12370101
    [Abstract] [Full Text] [Related]

  • 18. Effects of levamisole administration on treatment with 6-mercaptopurine riboside of mice bearing L1210 leukemia cells.
    Miura T, Nogiwa E, Kurashige S, Maekawa T.
    Cancer Res; 1980 Dec 15; 40(12):4813-6. PubMed ID: 7438114
    [Abstract] [Full Text] [Related]

  • 19. Effects of 7-R-O-methylnogarol (menogaril) on L1210 cell progression in vitro and in vivo.
    Adams EG, Bhuyan BK.
    Cancer Res; 1986 Dec 15; 46(12 Pt 1):6125-30. PubMed ID: 2946401
    [Abstract] [Full Text] [Related]

  • 20. The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds.
    Fariss MW, Fortuna MB, Everett CK, Smith JD, Trent DF, Djuric Z.
    Cancer Res; 1994 Jul 01; 54(13):3346-51. PubMed ID: 8012947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.